Lv1
8 积分 2024-06-26 加入
Allergic rhinitis
2个月前
已完结
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer
2个月前
已完结
ESR1 mutations in breast cancer
2个月前
已完结
Fulvestrant in advanced breast cancer: evidence to date and place in therapy
2个月前
已完结
Palbociclib and Fulvestrant in Breast Cancer
2个月前
已完结
Harnessing STING Signaling and Natural Killer Cells overcomes PARP Inhibitor Resistance in Homologous Recombination Deficient Breast Cancer
2个月前
已完结
Combining STING Agonists with PARP Inhibitors Mounts an NK-Dependent Defense against Therapy-Resistant Breast Cancer
2个月前
已完结
PARP (Poly ADP‐ribose Polymerase) Family in Health and Disease
3个月前
已完结
Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response
3个月前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
3个月前
已完结
皖公网安备34019202002308
